Skip to main content
Oncotarget logoLink to Oncotarget
. 2022 Nov 2;13:1215. doi: 10.18632/oncotarget.28296

Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy

Rajnish Nagarkar 1, Darshana Patil 2, Sewanti Limaye 3, Pradip Devhare 2, Ashwini Ghaisas 2, Navin Srivastava 2, Sachin Apurwa 2, Sanket Patil 2, Jinumary John 2, Zarrine Raazi 2, Aditya Shreenivas 4, Janani Sambath 5,6, Ajay Srinivasan 2, Prashant Kumar 2,5,6, Dadasaheb Akolkar 2,, Rajan Datar 2
PMCID: PMC9629807  PMID: 36342460

This article has an addendum: The patient has previously consented to publication of de-identified findings.

Original article: Oncotarget. 2020; 11:4195–4200. 4195-4200. https://doi.org/10.18632/oncotarget.27793


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES